[The Chinese consensus on the diagnosis and treatment of mycobacterium tuberculosis infection in allogeneic hematopoietic stem cell transplantation patients (2023)].
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2023 Feb 14;44(2):98-105. doi: 10.3760/cma.j.issn.0253-2727.2023.02.003.
Abstract
摘要
相似文献
1
[The Chinese consensus on the diagnosis and treatment of mycobacterium tuberculosis infection in allogeneic hematopoietic stem cell transplantation patients (2023)].《异基因造血干细胞移植患者结核分枝杆菌感染诊断与治疗中国专家共识（2023年版）》
Zhonghua Xue Ye Xue Za Zhi. 2023 Feb 14;44(2):98-105. doi: 10.3760/cma.j.issn.0253-2727.2023.02.003.
2
Next-generation sequencing assistance in the diagnosis of active tuberculosis following allogeneic hematopoietic stem cell transplantation: A case series.下一代测序技术辅助诊断异基因造血干细胞移植后活动性肺结核：病例系列
J Infect Chemother. 2025 Apr;31(4):102683. doi: 10.1016/j.jiac.2025.102683. Epub 2025 Mar 19.
3
Prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation comparing tuberculin skin test and interferon-gamma release assay.比较结核菌素皮肤试验和干扰素-γ释放试验在造血干细胞移植中潜伏性结核分枝杆菌感染的患病率。
Eur J Clin Microbiol Infect Dis. 2023 Jul;42(7):899-902. doi: 10.1007/s10096-023-04613-w. Epub 2023 May 1.
4
An update on Mycobacterium tuberculosis infection after hematopoietic stem cell transplantation in adults.成人造血干细胞移植后分枝杆菌感染的研究进展。
Clin Transplant. 2018 Dec;32(12):e13430. doi: 10.1111/ctr.13430. Epub 2018 Nov 11.
5
Incidence and clinical profile of tuberculosis after allogeneic stem cell transplantation.异基因造血干细胞移植后结核病的发病率及临床特征
Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12794. Epub 2017 Nov 26.
6
[The Chinese consensus on the management of cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation patients (2022)].《2022年异基因造血干细胞移植患者巨细胞病毒感染管理的中国专家共识》
Zhonghua Xue Ye Xue Za Zhi. 2022 Aug 14;43(8):617-623. doi: 10.3760/cma.j.issn.0253-2727.2022.08.001.
7
[The Chinese expert consensus on hematopoietic stem cell transplantation for malignant lymphoma(2018)].《中国恶性淋巴瘤造血干细胞移植专家共识（2018年版）》
Zhonghua Zhong Liu Za Zhi. 2018 Dec 23;40(12):927-934. doi: 10.3760/cma.j.issn.0253-3766.2018.12.011.
8
[Chinese expert consensus on allogeneic hematopoietic stem cell transplantation for cerebral adrenoleukodystrophy (2023)].《脑型肾上腺脑白质营养不良异基因造血干细胞移植中国专家共识（2023年版）》
Zhonghua Er Ke Za Zhi. 2024 Mar 25;62(4):303-309. doi: 10.3760/cma.j.cn112140-20231019-00302.
9
Disseminated tuberculosis following reduced-intensity cord blood transplantation for adult patients with hematological diseases.血液系统疾病成年患者接受低强度脐血移植后的播散性肺结核
Bone Marrow Transplant. 2005 Jan;35(1):91-7. doi: 10.1038/sj.bmt.1704740.
10
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update.中华血液学分会关于异基因造血干细胞移植适应证、预处理方案及供者选择的专家共识（2021 年版）
J Hematol Oncol. 2021 Sep 15;14(1):145. doi: 10.1186/s13045-021-01159-2.
引用本文的文献
1
Refractory splenic tuberculosis in acute myeloid Leukemia: The role of advanced diagnostics and surgical intervention.急性髓系白血病中的难治性脾结核：先进诊断方法及外科干预的作用
J Clin Tuberc Other Mycobact Dis. 2025 Apr 11;40:100525. doi: 10.1016/j.jctube.2025.100525. eCollection 2025 Aug.
本文引用的文献
1
Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia.成人血液恶性肿瘤和造血干细胞移植患者的分枝杆菌感染：第 8 届欧洲白血病感染会议指南。
Lancet Infect Dis. 2022 Dec;22(12):e359-e369. doi: 10.1016/S1473-3099(22)00227-4. Epub 2022 May 27.
2
Study of clinical characteristics, risk factors and outcomes for tuberculosis post allogeneic stem cell transplant: never count it out.异基因造血干细胞移植后结核病的临床特征、危险因素及预后研究：绝不可掉以轻心。
Ther Adv Infect Dis. 2021 Apr 12;8:20499361211008674. doi: 10.1177/20499361211008674. eCollection 2021 Jan-Dec.
3
Latent Tuberculosis in Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Strategies to Prevent Disease Activation in an Endemic Population.造血干细胞移植中的潜伏性结核病：在流行地区预防疾病激活的诊断和治疗策略。
Biol Blood Marrow Transplant. 2020 Jul;26(7):1350-1354. doi: 10.1016/j.bbmt.2020.03.013. Epub 2020 Mar 19.
4
Frequency, Risk Factors, and Outcome of Active Tuberculosis following Allogeneic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植后活动性结核病的频率、危险因素和结局。
Biol Blood Marrow Transplant. 2020 Jun;26(6):1203-1209. doi: 10.1016/j.bbmt.2020.02.018. Epub 2020 Feb 24.
5
Allo-HSCT recipients with invasive fungal disease and ongoing immunosuppression have a high risk for developing tuberculosis.异基因造血干细胞移植受者合并侵袭性真菌病和持续免疫抑制，发生结核病的风险很高。
Sci Rep. 2019 Dec 31;9(1):20402. doi: 10.1038/s41598-019-56013-w.
6
A Survey of Anxiety and Depressive Symptoms in Pulmonary Tuberculosis Patients With and Without Tracheobronchial Tuberculosis.伴有和不伴有气管支气管结核的肺结核患者焦虑和抑郁症状的调查
Front Psychiatry. 2018 Jul 19;9:308. doi: 10.3389/fpsyt.2018.00308. eCollection 2018.
7
The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general population.异基因造血干细胞移植受者中结核病的高度关注：与普通人群相比发病率高。
PLoS One. 2017 Mar 9;12(3):e0173250. doi: 10.1371/journal.pone.0173250. eCollection 2017.
8
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.美国胸科学会/疾病控制与预防中心/美国传染病学会官方临床实践指南：药物敏感型肺结核的治疗
Clin Infect Dis. 2016 Oct 1;63(7):e147-e195. doi: 10.1093/cid/ciw376. Epub 2016 Aug 10.
9
Long-term risk of tuberculosis in haematopoietic stem cell transplant recipients: a 10-year nationwide study.造血干细胞移植受者患结核病的长期风险：一项为期10年的全国性研究。
Int J Tuberc Lung Dis. 2015 Jan;19(1):58-64. doi: 10.5588/ijtld.14.0301.
10
Infections Caused by Mycobacterium tuberculosis in Recipients of Hematopoietic Stem Cell Transplantation.造血干细胞移植受者中由结核分枝杆菌引起的感染。
Front Oncol. 2014 Aug 26;4:231. doi: 10.3389/fonc.2014.00231. eCollection 2014.
Zotero 插件